Skip to main content
SpringerLink
Log in

Thinking positive with quinupristin/dalfopristin

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lamb HM, Figgitt DP, Faulds D. Quinupristin/dalfopristin: a review of its use in the management of serious Gram-positive infections. Drugs 1999 Dec; 58(6): 1061–97

    Article  PubMed  CAS  Google Scholar 

  2. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999 Feb 18; 340: 493–501

    Article  PubMed  CAS  Google Scholar 

  3. Srinath L, Kurkimilis E, Prokocimer P, et al. Quinupristin/dalfopristin (Synercid Rm) therapy of methicillin-resistant Staphylococcus aureus infections [abstract no. P593]. J Chemother 1999 Jul; 44 Suppl. A: 169

    Google Scholar 

  4. Linden PK, Moellering RC, Synercid Emergency-Use Study Group. Efficacy and safety of quinupristin/dalfopristin (RP59500, Synercid) for the treatment of vancomycin-resistant Enterococcus faecium (VREF) infections in an ongoing emergency use program [abstract]. 8th International Congress on Infectious Diseases: 1998 May 15: Boston (MA): 200

    Google Scholar 

  5. Moellering RC, Linden PK, Reinhardt J, et al. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1999; 44: 251–61

    Article  PubMed  CAS  Google Scholar 

  6. Nichols RL, Graham DR, Barriere SL, et al. Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/ dalfopristin versus cefazolin, oxacillin or vancomycin. J Antimicrob Chemother 1999; 44: 263–73

    Article  PubMed  CAS  Google Scholar 

  7. Fagon J-Y, Patrick H, Haas DW, et al. Treatment of gram-positive nosocomial pneumonia: prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Am J Respir Crit Care Med 2000 Mar; 161 (3 Pt 1): 753–62

    PubMed  CAS  Google Scholar 

  8. Linden PK, Pasculle AW, McDevitt D. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort. J Antimicrob Chemother 1997 May; 39 Suppl. A: 145–51

    Article  PubMed  CAS  Google Scholar 

  9. Chow JW, Davidson A, Sanford III E, et al. Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy. Clin Infect Dis 1997 Jan; 24: 91–2

    Article  PubMed  CAS  Google Scholar 

  10. Bompart F, Dorr M, Bekele T, et al. Overview of the safety and tolerability of quinupristin/dalfopristin (Synercid, RP 59500) in the global development program [abstract no. 2318]. 20th International Congress of Chemotherapy 1997 Jun 29: Sydney: 44–5

    Google Scholar 

  11. Linden P, Talbot G, Bompart F. Liver histopathology in liver transplant recipients with hyperbilirubinemia during quinupristin/dalfopristin therapy [poster]. 4th International Conference in the Macrolides, Azalides, Streptogramins and Ketolides 1998 Jan 21–23: Barcelona

    Google Scholar 

  12. Talbot GH, Zhu GR. Characterization of arthralgias/myalgias associated with quinupristin/dalfopristin (Synercid) [abstract]. Clin Infect Dis 1998 Oct; 27: 965

    Google Scholar 

  13. Rhône-Poulenc Rorer Pharmaceuticals Inc. Prescribing information. Synercid® I.V. (quinupristin and dalfopristin for injection). Collegeville (PA), USA, 1999

  14. Anon. Quinupristin/dalfopristin. Med Lett Drugs Ther 1999 Nov 19; 41 (9): 109-10

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thinking positive with quinupristin/dalfopristin. Drugs Ther. Perspect 15, 1–5 (2000). https://doi.org/10.2165/00042310-200015080-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200015080-00001

Keywords

Search

Navigation